Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2026 Filed Mar 24, 2026 21:24 UTC |
Urbach Tanya DurkeeDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 574,385 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033963 · tm269618-8_4seq1.xml · derivative · entry 1 Urbach Tanya Durkee · CIK 0001897672 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,385 Underlying: Common Stock · 574,385 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:23 UTC |
SIMES STEPHEN MDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 574,385 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033962 · tm269618-7_4seq1.xml · derivative · entry 1 SIMES STEPHEN M · CIK 0000905479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,385 Underlying: Common Stock · 574,385 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:23 UTC |
Ndhlovu Lishomwa CDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 574,385 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033961 · tm269618-6_4seq1.xml · derivative · entry 1 Ndhlovu Lishomwa C · CIK 0001898357 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,385 Underlying: Common Stock · 574,385 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:22 UTC |
Lalezari Jacob PChief Executive Officer
|
GrantNon-qualified stock option (right to buy) · Derivative | 4,874,691 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033960 · tm269618-5_4seq1.xml · derivative · entry 1 Lalezari Jacob P · CIK 0002001963 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,874,691 Underlying: Common Stock · 4,874,691 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: 1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:22 UTC |
Hoffman Robert E.Chief Financial Officer
|
GrantNon-qualified stock option (right to buy) · Derivative | 4,874,691 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033958 · tm269618-4_4seq1.xml · derivative · entry 1 Hoffman Robert E. · CIK 0001166288 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,874,691 Underlying: Common Stock · 4,874,691 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: 1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:21 UTC |
Dunlap RyanDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 574,385 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033957 · tm269618-3_4seq1.xml · derivative · entry 1 Dunlap Ryan · CIK 0001554742 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,385 Underlying: Common Stock · 574,385 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:20 UTC |
Brunke Karen JDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 574,385 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033955 · tm269618-2_4seq1.xml · derivative · entry 1 Brunke Karen J · CIK 0001922660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,385 Underlying: Common Stock · 574,385 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: The stock option will vest in 12 approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2026 through March 2027. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:20 UTC |
Blok TylerChief Legal Officer
|
GrantNon-qualified stock option (right to buy) · Derivative | 3,249,794 | $0.00 Strike: $0.28 | $0.00 |
DisclosureSEC source: 0001104659-26-033954 · tm269618-1_4seq1.xml · derivative · entry 1 Blok Tyler · CIK 0001990234 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,249,794 Underlying: Common Stock · 3,249,794 shares Expires 2036-03-20 F1 · shares: This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan"). F2 · derivative.exercise_date: 812,448 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030. Read SEC document |
| May 15, 2025 Filed May 23, 2025 00:31 UTC |
Hoffman Robert E.Chief Financial Officer
|
GrantNon-qualified stock option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001104659-25-052122 · tm2515909-2_4seq1.xml · derivative · entry 1 Hoffman Robert E. · CIK 0001166288 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2035-05-15 F1 · shares: This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan"). F2 · derivative.exercise_date: 250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:48 UTC |
Urbach Tanya DurkeeDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001104659-24-112761 · tm2427081-7_4seq1.xml · derivative · entry 1 Urbach Tanya Durkee · CIK 0001897672 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-10-28 F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:48 UTC |
SIMES STEPHEN MDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001104659-24-112760 · tm2427081-6_4seq1.xml · derivative · entry 1 SIMES STEPHEN M · CIK 0000905479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-10-28 F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:47 UTC |
Ndhlovu Lishomwa CDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001104659-24-112758 · tm2427081-5_4seq1.xml · derivative · entry 1 Ndhlovu Lishomwa C · CIK 0001898357 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-10-28 F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:46 UTC |
Dunlap RyanDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001104659-24-112756 · tm2427081-3_4seq1.xml · derivative · entry 1 Dunlap Ryan · CIK 0001554742 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-10-28 F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:47 UTC |
Lalezari Jacob PChief Executive Officer
|
GrantNon-qualified stock option (right to buy) · Derivative | 3,000,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001104659-24-112757 · tm2427081-4_4seq1.xml · derivative · entry 1 Lalezari Jacob P · CIK 0002001963 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2034-10-28 F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: 250,000 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:45 UTC |
Brunke Karen JDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001104659-24-112755 · tm2427081-2_4seq1.xml · derivative · entry 1 Brunke Karen J · CIK 0001922660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-10-28 F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: 266,664 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2025. Read SEC document |
| October 28, 2024 Filed Oct 31, 2024 01:45 UTC |
Blok TylerChief Legal Officer
|
GrantNon-qualified stock option (right to buy) · Derivative | 1,250,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001104659-24-112753 · tm2427081-1_4seq1.xml · derivative · entry 1 Blok Tyler · CIK 0001990234 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2034-10-28 F1 · shares: This grant was approved by the Company's Compensation Committee on October 28, 2024 and represents the annual grant awarded to the individual for fiscal year 2025. This award is made consistent with, and utilizes shares from, the Issuer's 2012 Equity Incentive Plan, as amended. F2 · derivative.exercise_date: 104,164 shares vested on the grant date, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from October 2024 through May 2028. Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 02:30 UTC |
Lalezari Jacob PChief Executive Officer
|
GrantNon-qualified stock option (right to buy) · Derivative | 3,000,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-24-032609 · tm248303-1_4seq1.xml · derivative · entry 1 Lalezari Jacob P · CIK 0002001963 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2034-03-07 F1 · derivative.exercise_date: The stock option will vest and become exercisable in 48 monthly installments beginning on April 7, 2024 and ending on March 7, 2028, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 630,222 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 12 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,222 Underlying: Common Stock · 630,222 shares Expires 2032-09-20 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F8 · derivative.exercise_date: 301,975 shares were fully vested and exercisable on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through January 2026. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 1,000,000 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 11 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2031-08-06 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F7 · derivative.exercise_date: 666,000 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on August 6, 2024. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 10 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-02-17 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F6 · derivative.exercise_date: 33,300 shares were fully vested and exercisable on January 3, 2024; the balance is scheduled to vest on February 17, 2024. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 9 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-22 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 8 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-02-21 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 7 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-16 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | Disposition to issuerNon-qualified stock option (right to buy) · Derivative | 630,222 | Not disclosed Strike: $0.58 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 6 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 630,222 shares Expires 2032-09-20 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F5 · derivative.exercise_date: 25% of the award vested on January 24, 2023, with the balance scheduled to vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | Disposition to issuerNon-qualified stock option (right to buy) · Derivative | 1,000,000 | Not disclosed Strike: $1.32 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 5 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000,000 shares Expires 2031-08-06 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F4 · derivative.exercise_date: Vesting was scheduled to occur in three equal annual installments beginning on August 6, 2022. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | Disposition to issuerNon-qualified stock option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $5.54 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 4 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2031-02-17 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F3 · derivative.exercise_date: Vesting was scheduled to occur in three equal annual installments beginning on February 17, 2022. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | Disposition to issuerNon-qualified stock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $5.57 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 3 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2030-07-22 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F1 · derivative.exercise_date: The option was fully vested and exercisable prior to January 3, 2024. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | Disposition to issuerNon-qualified stock option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $1.10 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 2 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2030-02-21 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F1 · derivative.exercise_date: The option was fully vested and exercisable prior to January 3, 2024. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC | Disposition to issuerNon-qualified stock option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $1.03 | Not disclosed |
DisclosureSEC source: 0001104659-24-001956 · tm242134-7_4seq1.xml · derivative · entry 1 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2030-01-16 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F1 · derivative.exercise_date: The option was fully vested and exercisable prior to January 3, 2024. Read SEC document |
|
| January 03, 2024 Filed Jan 6, 2024 02:03 UTC |
SIMES STEPHEN MDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-24-001954 · tm242134-5_4seq1.xml · derivative · entry 1 SIMES STEPHEN M · CIK 0000905479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-01-03 F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:04 UTC |
Urbach Tanya DurkeeDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-24-001955 · tm242134-6_4seq1.xml · derivative · entry 2 Urbach Tanya Durkee · CIK 0001897672 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-01-03 F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:02 UTC |
Ndhlovu Lishomwa CDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-24-001953 · tm242134-4_4seq1.xml · derivative · entry 1 Ndhlovu Lishomwa C · CIK 0001898357 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2024-01-03 F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:01 UTC |
Brunke Karen JDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-24-001951 · tm242134-2_4seq1.xml · derivative · entry 1 Brunke Karen J · CIK 0001922660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-01-03 F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:02 UTC |
Dunlap RyanDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-24-001952 · tm242134-3_4seq1.xml · derivative · entry 1 Dunlap Ryan · CIK 0001554742 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2034-01-03 F1 · derivative.exercise_date: 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:01 UTC |
Blok TylerEVP of Legal Affairs
|
GrantNon-qualified stock option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-24-001950 · tm242134-1_4seq1.xml · derivative · entry 4 Blok Tyler · CIK 0001990234 · EVP of Legal Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2034-01-03 F4 · derivative.exercise_date: 145,831 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through May 2027. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:01 UTC |
Blok TylerEVP of Legal Affairs
|
GrantNon-qualified stock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.21 | Not disclosed |
DisclosureSEC source: 0001104659-24-001950 · tm242134-1_4seq1.xml · derivative · entry 3 Blok Tyler · CIK 0001990234 · EVP of Legal Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-07-25 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F3 · derivative.exercise_date: 35,415 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service beginning at the end of January 2024 through July 2026. Read SEC document |
| January 03, 2024 Filed Jan 6, 2024 02:01 UTC |
Blok TylerEVP of Legal Affairs
|
Disposition to issuerNon-qualified stock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.67 | Not disclosed |
DisclosureSEC source: 0001104659-24-001950 · tm242134-1_4seq1.xml · derivative · entry 2 Blok Tyler · CIK 0001990234 · EVP of Legal Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2032-07-25 F2 · price: The outstanding option was cancelled in exchange for a new option having a lower exercise price. F1 · derivative.exercise_date: 25% of the grant vested on July 25, 2023, with the balance vesting in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) beginning at the end of August 2023 through July 2026. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 01:09 UTC |
Arman Arvin CyrusPresident
|
GrantWarrants (right to buy) · Derivative | 434,782 | Not disclosed Strike: $0.50 | Not disclosed |
DisclosureSEC source: 0001104659-23-022094 · tm236870-1_4seq1.xml · derivative · entry 2 Arman Arvin Cyrus · CIK 0001939191 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,782 Underlying: Common Stock · 434,782 shares Expires not disclosed F1 · shares: The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the "Offering"). Each "Unit" consists of one share of common stock and one warrant to purchase one share of common stock. F2 · shares: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price. F2 · price: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price. F3 · derivative.exercise_date: The warrants will become exercisable in full on the final closing date of the Offering. The warrants will expire five years after the exercise date. F3 · derivative.expiration_date: The warrants will become exercisable in full on the final closing date of the Offering. The warrants will expire five years after the exercise date. F1 · derivative.underlying_shares: The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the "Offering"). Each "Unit" consists of one share of common stock and one warrant to purchase one share of common stock. F2 · derivative.underlying_shares: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price. F2 · balance_after: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 01:09 UTC |
Arman Arvin CyrusPresident
|
GrantCommon Stock | 434,782 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-022094 · tm236870-1_4seq1.xml · nonDerivative · entry 1 Arman Arvin Cyrus · CIK 0001939191 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,081,334 F1 · shares: The reported securities are included within Units purchased by the reporting person in a private placement directly with the Company. The terms are identical to a concurrent offering being conducted through a placement agent (the "Offering"). Each "Unit" consists of one share of common stock and one warrant to purchase one share of common stock. F2 · shares: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price. F2 · price: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price. F2 · balance_after: The number of Units and the corresponding numbers of shares and warrants have been calculated based on a purchase price of $0.23 per Unit, which was equal to 90% of the intraday volume weighted average price of the common stock on January 12, 2023, the date of the first closing in the Offering. The number of Units and corresponding numbers of shares and warrants purchased in the Offering will increase if 90% of the intraday volume weighted average price of a share of common stock on the final closing date in the Offering is lower than $0.23. The revised numbers will be calculated by dividing $100,000 by such lower price. Read SEC document |
| November 30, 2022 Filed Dec 1, 2022 01:34 UTC | GrantCommon Stock | 12,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-123366 · tm2231600-4_4seq1.xml · nonDerivative · entry 1 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,207 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
|
| November 30, 2022 Filed Dec 1, 2022 01:33 UTC | GrantCommon Stock | 16,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-123365 · tm2231600-3_4seq1.xml · nonDerivative · entry 1 Kelly Scott A. · CIK 0001703394 · CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184,037 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
|
| November 28, 2022 Filed Dec 1, 2022 01:34 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 4,585,536 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001104659-22-123366 · tm2231600-4_4seq1.xml · derivative · entry 2 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,585,536 Underlying: Common Stock · 4,585,536 shares Expires 2032-11-28 F2 · derivative.exercise_date: 477,660 shares vested on November 28, 2022; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from November 2022 through May 2026. Read SEC document |
|
| November 28, 2022 Filed Dec 1, 2022 01:33 UTC | GrantNon-qualified stock option (right to buy) · Derivative | 2,315,439 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001104659-22-123365 · tm2231600-3_4seq1.xml · derivative · entry 3 Kelly Scott A. · CIK 0001703394 · CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,315,439 Underlying: Common Stock · 2,315,439 shares Expires 2032-11-28 F2 · derivative.exercise_date: 241,190 shares vested on November 28, 2022; the balance will vest on a monthly basis as follows (i) 48,238 shares at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended), from November 2022 through February 2025, and (ii) 48,239 shares at the conclusion of each month of Continuous Service, from March 2025 through May 2026. Read SEC document |
|
| November 15, 2022 Filed Nov 17, 2022 23:53 UTC | GrantCommon Stock | 10,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-119981 · tm2230762-3_4seq1.xml · nonDerivative · entry 1 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,199 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
|
| November 15, 2022 Filed Nov 17, 2022 23:51 UTC | GrantCommon Stock | 15,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-119979 · tm2230762-2_4seq1.xml · nonDerivative · entry 1 Kelly Scott A. · CIK 0001703394 · CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167,110 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
|
| November 15, 2022 Filed Nov 17, 2022 23:49 UTC |
Ray Nitya G.Chief Technology Officer
|
GrantCommon Stock | 13,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-119978 · tm2230762-1_4seq1.xml · nonDerivative · entry 1 Ray Nitya G. · CIK 0001709522 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,090 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
| October 31, 2022 Filed Nov 3, 2022 00:57 UTC | GrantCommon Stock | 17,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-114101 · tm2228860-4_4seq1.xml · nonDerivative · entry 1 Kelly Scott A. · CIK 0001703394 · CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,151,876 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
|
| October 31, 2022 Filed Nov 3, 2022 00:55 UTC | GrantCommon Stock | 12,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-114100 · tm2228860-3_4seq1.xml · nonDerivative · entry 1 Migliarese Antonio · CIK 0001864040 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,392 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
|
| October 31, 2022 Filed Nov 3, 2022 00:52 UTC |
Ray Nitya G.Chief Technology Officer
|
GrantCommon Stock | 16,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-114098 · tm2228860d2_4seq.xml · nonDerivative · entry 1 Ray Nitya G. · CIK 0001709522 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,419 F1 · shares: Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary. Read SEC document |
| October 24, 2022 Filed Nov 1, 2022 21:04 UTC |
SIMES STEPHEN MDirector
|
GrantNon-qualified stock option (right to buy) · Derivative | 178,012 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001104659-22-113563 · tm2228860-1_4seq1.xml · derivative · entry 1 SIMES STEPHEN M · CIK 0000905479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,012 Underlying: Common Stock · 178,012 shares Expires 2032-10-24 F1 · derivative.exercise_date: The options will vest in eight equal monthly installments beginning on November 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.